General Information
Product name
IB DCE
Company
Subspeciality
Multiple
Modality
MR
Disease targeted
Tumors
Main task
Not specified
Technical Specifications
Population
Not specified
Patient population age
Not specified
Input
Dynamically acquired DCE datasets
Input format
DICOM
Output
Quantitative output of multi-parameter DCE maps
Output format
DICOM
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment
Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Trigger for analysis
Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click
Processing time
10 - 60 seconds
Regulatory Information
CE Certification
Pathway:
MDD
Class:
Class I
Verified by Health AI Register
FDA Certification
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
01-2013
AI Platforms
Bayer Pharmaceuticals, Blackford Analysis, Medimsight, TeraRecon
Resellers
Aycan medical systems, CorTechs Labs, Pixmeo, QMENTA
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Subscription
Based on
Number of analyses, Number of installations, Number of users
Evidence & Research
No research papers or evidence available for this product.
Source: vendor | First published: Jul 31, 2020 | Last updated: Jul 9, 2025